Drug administration controller

US9333316B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9333316-B2
Application numberUS-201213475136-A
CountryUS
Kind codeB2
Filing dateMay 18, 2012
Priority dateJan 17, 2006
Publication dateMay 10, 2016
Grant dateMay 10, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A drug administration controller has a sensor that generates a sensor signal to a physiological measurement device, which measures a physiological parameter in response. A control output responsive to the physiological parameter or a metric derived from the physiological parameter causes a drug administration device to affect the treatment of a person, such as by initiating, pausing, halting or adjusting the dosage of drugs administered to the person.

First claim

Opening claim text (preview).

What is claimed is: 1. A drug administration method comprising: receiving, over a period of time, a signal indicative of at least one physiological parameter from a noninvasive optical sensor attached to a patient; determining, based on the signal, a plurality of measurements of the at least one physiological parameter, each of the plurality of measurements indicative of a value of the at least one physiological parameter at a different time during the period of time; determining, based on the plurality of measurements, at least one parameter trend for the at least one physiological parameter, the at least one parameter trend indicating a rate at which the at least one physiological parameter is increasing or decreasing over the period of time; and controlling a drug administration device based at least on one of the at least one parameter trends, wherein the at least one physiological parameter is a measure of blood methemoglobin (HbMet). 2. The drug administration method according to claim 1 , further comprising deriving at least one of a parameter limit, a parameter pattern, or a parameter variability. 3. The drug administration method according to claim 1 , wherein controlling comprises pausing the drug administration device when HbMet is trending upward. 4. The drug administration method according to claim 1 , wherein controlling comprises pausing the drug administration device when HbMet is above a HbMet limit. 5. A drug administration controller comprising: at least one noninvasive optical sensor that generates, over a period of time, at least one sensor signal in response to a physiological state of a living being; at least one physiological measurement device configured to: determine, in response to the at least one sensor signal, a plurality of measurements of at least one physiological parameter, each of the plurality of measurements indicative of a value of the at least one physiological parameter at a different time during the period of time, said at least on physiological parameter including methemoglobin (HbMet); and determine, based on the plurality of measurements, at least one trend for the at least one physiological parameter, the at least one trend indicating a rate at which the at least one physiological parameter is increasing or decreasing over the period of time; a rule-based processor that generates a control output in response to the at least one trend; and a drug administration device responsive to one or more control outputs so as to affect the treatment of the living being including at least one of initiating, pausing, halting or adjusting the dosage of administered drugs. 6. The drug administration controller according to claim 5 , wherein the drug administration device is at least one of a drug infusion device or a medical gas inhalation device. 7. The drug administration controller according to claim 5 , further comprising a sound sensor attached proximate to a neck site so as to measure respiration rate.

Assignees

Inventors

Classifications

  • hematocrit · CPC title

  • Blood pressure (A61M2230/04 takes precedence) · CPC title

  • Acoustical, e.g. ultrasonic, measuring means · CPC title

  • Parameter used as control input for the apparatus · CPC title

  • local, e.g. within room or hospital · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9333316B2 cover?
A drug administration controller has a sensor that generates a sensor signal to a physiological measurement device, which measures a physiological parameter in response. A control output responsive to the physiological parameter or a metric derived from the physiological parameter causes a drug administration device to affect the treatment of a person, such as by initiating, pausing, halting or…
Who is the assignee on this patent?
Kiani Massi E, Masimo Corp
What technology area does this patent fall under?
Primary CPC classification A61M16/12. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue May 10 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).